Literature DB >> 21406679

Intratumor heterogeneity in evolutionary models of tumor progression.

Rick Durrett1, Jasmine Foo, Kevin Leder, John Mayberry, Franziska Michor.   

Abstract

With rare exceptions, human tumors arise from single cells that have accumulated the necessary number and types of heritable alterations. Each such cell leads to dysregulated growth and eventually the formation of a tumor. Despite their monoclonal origin, at the time of diagnosis most tumors show a striking amount of intratumor heterogeneity in all measurable phenotypes; such heterogeneity has implications for diagnosis, treatment efficacy, and the identification of drug targets. An understanding of the extent and evolution of intratumor heterogeneity is therefore of direct clinical importance. In this article, we investigate the evolutionary dynamics of heterogeneity arising during exponential expansion of a tumor cell population, in which heritable alterations confer random fitness changes to cells. We obtain analytical estimates for the extent of heterogeneity and quantify the effects of system parameters on this tumor trait. Our work contributes to a mathematical understanding of intratumor heterogeneity and is also applicable to organisms like bacteria, agricultural pests, and other microbes.

Entities:  

Mesh:

Year:  2011        PMID: 21406679      PMCID: PMC3122322          DOI: 10.1534/genetics.110.125724

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  34 in total

1.  Stochastic models for subpopulation emergence in heterogeneous tumors.

Authors:  S Michelson; K Ito; H T Tran; J T Leith
Journal:  Bull Math Biol       Date:  1989       Impact factor: 1.758

2.  The fate of competing beneficial mutations in an asexual population.

Authors:  P J Gerrish; R E Lenski
Journal:  Genetica       Date:  1998       Impact factor: 1.082

3.  The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.

Authors:  Lars Häggarth; Gert Auer; Christer Busch; Mona Norberg; Michael Häggman; Lars Egevad
Journal:  Scand J Urol Nephrol       Date:  2005

4.  Mutation rate of normal and malignant human lymphocytes.

Authors:  R Seshadri; R J Kutlaca; K Trainor; C Matthews; A A Morley
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

5.  A stochastic model for the origin and treatment of tumors containing drug-resistant cells.

Authors:  A J Coldman; J H Goldie
Journal:  Bull Math Biol       Date:  1986       Impact factor: 1.758

Review 6.  Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations.

Authors:  R E Lenski; M Travisano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

7.  Tumor heterogeneity affects the precision of microarray analysis.

Authors:  Maureen O'Sullivan; Vikram Budhraja; Yoel Sadovsky; John D Pfeifer
Journal:  Diagn Mol Pathol       Date:  2005-06

8.  Stochastic modeling of drug resistance in cancer.

Authors:  Natalia Komarova
Journal:  J Theor Biol       Date:  2005-09-27       Impact factor: 2.691

Review 9.  Quinoline antimalarials: mechanisms of action and resistance.

Authors:  M Foley; L Tilley
Journal:  Int J Parasitol       Date:  1997-02       Impact factor: 3.981

10.  Evidence of tumor heterogeneity in cervical cancers and lymph node metastases as determined by flow cytometry.

Authors:  H N Nguyen; B U Sevin; H E Averette; R Ramos; P Ganjei; J Perras
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

View more
  58 in total

Review 1.  Big Bang Tumor Growth and Clonal Evolution.

Authors:  Ruping Sun; Zheng Hu; Christina Curtis
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  The dynamics of adapting, unregulated populations and a modified fundamental theorem.

Authors:  James P O'Dwyer
Journal:  J R Soc Interface       Date:  2012-09-19       Impact factor: 4.118

3.  Determinants of Genetic Diversity of Spontaneous Drug Resistance in Bacteria.

Authors:  Alejandro Couce; Alexandro Rodríguez-Rojas; Jesús Blázquez
Journal:  Genetics       Date:  2016-05-10       Impact factor: 4.562

4.  Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.

Authors:  Alba Mota; Eva Colás; Pablo García-Sanz; Irene Campoy; Alejandro Rojo-Sebastián; Sonia Gatius; Ángel García; Luis Chiva; Sonsoles Alonso; Antonio Gil-Moreno; Xavier González-Tallada; Berta Díaz-Feijoo; August Vidal; Patrycja Ziober-Malinowska; Marcin Bobiński; Rafael López-López; Miguel Abal; Jaume Reventós; Xavier Matias-Guiu; Gema Moreno-Bueno
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

5.  Modeling the Subclonal Evolution of Cancer Cell Populations.

Authors:  Diego Chowell; James Napier; Rohan Gupta; Karen S Anderson; Carlo C Maley; Melissa A Wilson Sayres
Journal:  Cancer Res       Date:  2017-11-29       Impact factor: 12.701

6.  Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer.

Authors:  C Sanchez; R Chan; P Bajgain; S Rambally; G Palapattu; M Mims; C M Rooney; A M Leen; M K Brenner; J F Vera
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-01-08       Impact factor: 5.554

7.  Analysis of the Myc-induced pancreatic β cell islet tumor microenvironment using imaging ToF-SIMS.

Authors:  Blake M Bluestein; Fionnuala Morrish; Daniel J Graham; Li Huang; David Hockenbery; Lara J Gamble
Journal:  Biointerphases       Date:  2018-08-28       Impact factor: 2.456

Review 8.  Modeling Tumor Clonal Evolution for Drug Combinations Design.

Authors:  Boyang Zhao; Michael T Hemann; Douglas A Lauffenburger
Journal:  Trends Cancer       Date:  2016-03

9.  Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors.

Authors:  Gene Young Cho; Linda Moy; Sungheon G Kim; Steven H Baete; Melanie Moccaldi; James S Babb; Daniel K Sodickson; Eric E Sigmund
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

10.  POPULATION GENETICS OF NEUTRAL MUTATIONS IN EXPONENTIALLY GROWING CANCER CELL POPULATIONS.

Authors:  Rick Durrett
Journal:  Ann Appl Probab       Date:  2013       Impact factor: 1.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.